Which is more profitable, Amgen or Revolution Medicines?

Amgen keeps more of every sale as profit.

Which grows faster, Amgen or Revolution Medicines?

Amgen grew its sales faster in recent years.

Which is cheaper, Amgen or Revolution Medicines?

Amgen costs less for each unit of yearly profit (lower P/E).

Which has less debt, Amgen or Revolution Medicines?

Revolution Medicines would need fewer years of earnings to pay off its debt.

AmgenAMGNvs

Revolution MedicinesRVMD

Amgen vs Revolution Medicines stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Amgen is more profitable, grows faster and is cheaper for its profits. Revolution Medicines has less debt.

Side by side

	Amgen	Revolution Medicines
	$252 billion	$37.3 billion
	21.0%	-3,768.3%
	+7.6%	−10.5%
	32.7×	No profit yet
	2.7 years	Net cash
	15.0%	-50.1%
	2.9%	–

Open Amgen Open Revolution Medicines

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Amgen vs Thermo Fisher Scientific · Amgen vs UnitedHealth · Amgen vs AbbVie · Amgen vs Bristol-Myers Squibb · Revolution Medicines vs Gilead Sciences